Evidence map›Paper›PMID 36374911›Full record

ArticlePloS one2022

Extracellular vesicles from focal segmental glomerulosclerosis pediatric patients induce STAT3 activation and mesangial cell proliferation.

Naile T Pekkucuksen, Lauren P Liu, Rasha Aly, Lawrence R Shoemaker, Abdel A Alli

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07056283 (The Study of Urinary Biomarkers in Patients With Hypomagnesemia), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07056283 recruitingnot on this mapstarted 2025, after this paper: background citation

The Study of Urinary Biomarkers in Patients With Hypomagnesemia

TypeobservationalSponsorUniversity of FloridaRan2025 to 2027Enrolled15ConditionsHypomagnesemia
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Inflammation in glomerular diseases.Frontiers in immunology · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Extracellular Vesicles as Source of Biomarkers in Glomerulonephritis.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Naile T PekkucuksenDivision Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, Florida, United States of America.
Lauren P LiuDepartment of Physiology and Aging, University of Florida, Gainesville, Florida, United States of America.
Rasha AlyDivision Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, Florida, United States of America.
Lawrence R ShoemakerDivision Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, Florida, United States of America.
Abdel A AlliDivision Pediatric Nephrology, Department of Pediatrics, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0003-4381-1172
University of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrimary focal segmental glomerulosclerosis (FSGS), a major cause of end-stage kidney disease (ESKD) in adolescents and young adults, is attributable to recognized genetic mutations in a minority of cases. For the majority with idiopathic primary FSGS, the cause of the disease is unknown. We hypothesize that extracellular vesicle (EVs), that carry information between podocytes and mesangial cells, may play a key role in disease progression. MATERIAL &

methodsA total of 30 participants (20 primary nephrotic syndrome/ 10 healthy controls) were enrolled in this study. Primary nephrotic syndrome subjects were grouped based on pathologic diagnosis. The FSGS group was compared to healthy control subjects based on demographic and clinical findings. EVs were isolated from the urine of each group before being characterized by Western blotting, transmission electron microscopy, and nanoparticle tracking analysis. The effects of the EVs from each group on normal human mesangial cells and activation of certain pathways were then investigated.

resultsBased on demographic and clinical findings, mean serum creatinine was significantly higher in the FSGS group than the normal healthy control group. The mean size of the EVs in the FSGS group was significantly higher than the healthy control group. The mesangial cells that were challenged with EVs isolated from FSGS patients showed significant upregulation of STAT-3, PCNA, Ki67, and cell proliferation. DISCUSSION: Our data demonstrate that EVs from FSGS patients stimulate mesangial cell proliferation in association with upregulation of the phospho-STAT-3 pathway. Additional studies are planned to identify the molecular cargo within the EVs from FSGS patients that contribute to the pathogenesis of FSGS.

Indexed as

Extracellular VesiclesGlomerulosclerosis, Focal SegmentalNephrotic SyndromePodocytesAdolescentCell ProliferationChildHumansSTAT3 Transcription FactorSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID36374911
PMCPMC9662727
OpenAlexW4308964091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.